Wakaizumi, Kenta
Shinohara, Yuta
Kawate, Morihiko
Matsudaira, Ko
Oka, Hiroyuki
Yamada, Keiko
Jabakhanji, Rami
Baliki, Marwan N.
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (19FG1001)
MEXT | Japan Society for the Promotion of Science (21K16564)
The foundation for Total Health Promotion is a Japanese foundation for a scientific health research.
Article History
Received: 6 November 2023
Accepted: 27 March 2024
First Online: 1 April 2024
Competing interests
: This research was partially supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21K16564), the Health Labour Sciences Research Grant (19FG1001), and the Foundation for Total Health Promotion. All authors have declared potential conflicts of interest as follows: KM reports receiving grants from the Ministry of Health, Labor and Welfare during the conduct of the study; grants and personal fees from AYUMI Pharmaceutical Corporation, Nippon Zoki Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd, Shionogi Co., Ltd., Eli Lilly Japan, Astellas Pharma Inc., Toto Ltd., Eisai Co., Ltd., Teijin Pharma Limited, Japan Inc., and Hisamitsu Pharmaceutical Co., Inc.; personal fees from Pfizer Inc., Janssen Pharmaceutical K.K., Kaken Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Daiichi Sankyo Company, Limited; grants from Sompo Holdings, Inc., MTG, NuVasive Japan , and Murata Manufacturing Co., Ltd.; grants from Okamura Corporation; and non-financial support from Trunk Solution Co., Ltd. outside the submitted work. HO received grants from Teijin Pharma Limited, grants from Pfizer Inc., grants from Fujifilm Medical Co., Ltd., grants and personal fees from AYUMI Pharmaceutical Corporation, Nippon Zoki Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Sompo Holdings, Inc., NuVasive Japan, and grants from Eli Lilly Japan. KW, YS, MK, KY, RJ, MNB have no competing interests to report.